Hydrochlorothiazide must not be given to pregnant women because it crosses the placenta and is distributed in breast milk. Neonatal jaundice, thrombocytopenia and electrolyte imbalance have been reported following maternal treatment. Reductions in maternal blood volume could also adversely affect placental perfusion. Treatment with large doses of thiazide diuretics can inhibit lactation.